A Long-term Extension Study of PCI-32765 (Ibrutinib) (CAN3001)
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study
Sponsor: Janssen Research & Development, LLC
This PHASE3 trial investigates Chronic Graft Versus Host Disease and Chronic Lymphocytic Leukemia and is currently actively recruiting participants. Janssen Research & Development, LLC leads this study, which shows 89 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
89 versions recorded-
Mar 2026 — Present [monthly]
Recruiting PHASE3
-
Feb 2026 — Mar 2026 [monthly]
Recruiting PHASE3
-
Jan 2026 — Feb 2026 [monthly]
Recruiting PHASE3
-
Dec 2025 — Jan 2026 [monthly]
Recruiting PHASE3
-
Nov 2025 — Dec 2025 [monthly]
Recruiting PHASE3
▶ Show 84 earlier versions
-
Oct 2025 — Nov 2025 [monthly]
Recruiting PHASE3
-
Sep 2025 — Oct 2025 [monthly]
Recruiting PHASE3
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Jun 2025 — Aug 2025 [monthly]
Recruiting PHASE3
-
May 2025 — Jun 2025 [monthly]
Recruiting PHASE3
-
Apr 2025 — May 2025 [monthly]
Recruiting PHASE3
-
Mar 2025 — Apr 2025 [monthly]
Recruiting PHASE3
-
Feb 2025 — Mar 2025 [monthly]
Recruiting PHASE3
-
Jan 2025 — Feb 2025 [monthly]
Recruiting PHASE3
Status: Enrolling By Invitation → Recruiting
-
Nov 2024 — Jan 2025 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2024 — Nov 2024 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Enrolling By Invitation PHASE3
-
May 2024 — Jun 2024 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2024 — May 2024 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2024 — Apr 2024 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2024 — Mar 2024 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2024 — Feb 2024 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2023 — Jan 2024 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2023 — Dec 2023 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2023 — Nov 2023 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2023 — Oct 2023 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2023 — Sep 2023 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2023 — Aug 2023 [monthly]
Enrolling By Invitation PHASE3
-
May 2023 — Jun 2023 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2023 — May 2023 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2023 — Apr 2023 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2023 — Mar 2023 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2023 — Feb 2023 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2022 — Dec 2022 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2022 — Nov 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2022 — Sep 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2022 — Jul 2022 [monthly]
Enrolling By Invitation PHASE3
-
May 2022 — Jun 2022 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2022 — May 2022 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2022 — Apr 2022 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2022 — Feb 2022 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2021 — Jan 2022 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2021 — Dec 2021 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2021 — Nov 2021 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE3
-
May 2021 — Jun 2021 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2021 — May 2021 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2021 — Apr 2021 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2021 — Mar 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2020 — Dec 2020 [monthly]
Enrolling By Invitation PHASE3
-
May 2020 — Oct 2020 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2020 — May 2020 [monthly]
Enrolling By Invitation PHASE3
Status: Recruiting → Enrolling By Invitation
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE3
Status: Enrolling By Invitation → Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2019 — Jan 2020 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2019 — Nov 2019 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2019 — Oct 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2019 — Sep 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2019 — Jul 2019 [monthly]
Enrolling By Invitation PHASE3
-
May 2019 — Jun 2019 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2019 — May 2019 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2019 — Apr 2019 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2019 — Feb 2019 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2018 — Jan 2019 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2018 — Dec 2018 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2018 — Oct 2018 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2018 — Sep 2018 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2018 — Aug 2018 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2017 — Mar 2018 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2017 — Dec 2017 [monthly]
Enrolling By Invitation PHASE3
Status: Recruiting → Enrolling By Invitation
-
Sep 2017 — Nov 2017 [monthly]
Recruiting PHASE3
Status: Enrolling By Invitation → Recruiting
-
Aug 2017 — Sep 2017 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2017 — Aug 2017 [monthly]
Enrolling By Invitation PHASE3
-
May 2017 — Jun 2017 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2017 — May 2017 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2017 — Apr 2017 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE3
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Research & Development, LLC
- Pharmacyclics LLC.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adelaide, Australia , Afula, Israel , Amsterdam, Netherlands , Ankara, Turkey (Türkiye) , Ann Arbor, United States , Antwerp, Belgium , Arkhangelsk, Russia , Athens, Greece , Barcelona, Spain , Battle Creek, United States and 148 more locations